Japanese drugmaker Shionogi's president
Isao Teshirogi, president of Japanese pharmaceutical firm Shionogi & Co., attends a press conference in Tokyo on March 4, 2022, over the company's COVID-19 vaccine under development.
- Product Code
- ILEA000934836
- Registered date
- 2022/3/04 00:00:00
- Credit
- Kyodo / Kyodo News Images
- Media source
- 2022 Kyodo News
- Media size
- 2806 × 3508 pixel
- Deployment size
- 572.43(KB)*
*File size when opened in Photoshop, etc.